Company Name : Minapharm Pharmaceuticals ISIN Code : EGS380G1C011 Reuters Code : MIPH.CA Content : Release from the company regarding the company's response to the auditor's reservations concerning the standalone and consolidated financial statements for the financial period ended on 30/06/2026.